BeStock  
Stocks › Biotechnology › SMMT

Summit Therapeutics SMMT

US equityMarket cap rank #1601BiotechnologyTop Gainers Yesterday
$9.95 −$0.62 (-5.87%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $10.08 +1.31%
Open$10.28
Prev close$10.57
Day range$9.89 – $10.61
Volume7.22M
Market cap$7.96B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±10.3%last 16 reports
Closed higher4 of 1625% of the time
Best reaction+19.6%
Worst reaction-26.2%

Stock move on the day after each report

+10.9%2023/Q2-12.2%2023/Q3-26.2%2023/Q4+19.6%2024/Q1-4.7%2024/Q2-14.6%2024/Q3-14.8%2024/Q4+13.1%2025/Q1-4.5%2025/Q3+0.2%2025/Q4-8.8%2026/Q2-12.2%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q34 Nov 2026After Market±9.0%-12.24%Bigger than priced
2026/Q223 Jul 2026After Market±16.0%-8.81%Within range
2025/Q423 Feb 2026After Market±9.4%+0.19%Within range
2025/Q320 Oct 2025Pre Market±21.6%-4.55%Within range
2025/Q11 May 2025After Market±12.4%+13.09%Bigger than priced
2024/Q424 Feb 2025Pre Market±14.5%-14.83%Bigger than priced
2024/Q330 Oct 2024Pre Market±9.8%-14.57%Bigger than priced
2024/Q26 Aug 2024Pre Market±15.8%-4.74%Within range
2024/Q11 May 2024Pre Market±26.0%+19.59%Within range
2023/Q420 Feb 2024Pre Market±22.2%-26.23%Bigger than priced
2023/Q37 Nov 2023Pre Market±31.7%-12.16%Within range
2023/Q29 Aug 2023Pre Market±19.7%+10.86%Within range
2023/Q111 May 2023Pre Market±12.0%-9.20%Within range
2022/Q49 Mar 2023Pre Market±20.4%-6.58%Within range
2020/Q317 Dec 2019Pre Market–-2.09%–
2020/Q211 Oct 2019Pre Market–-5.71%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$214.61M+8.4% YoY
Net profit-$208.39M+10.1% YoY
Diluted EPS-$0.26+16.1% YoY
Free cash flow-$160.21M-72.0% YoY
Operating cash flow-$159.81M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-61.2MDec '24$-62.9MMar '25$-565.7MJun '25$-231.8MSep '25$-219.1MDec '25$-189.4MMar '26$-215.7MJun '26$-208.4MSep '26

Profitability & balance sheet

Return on equity-220.0%
Return on assets-174.5%
Return on invested capital-212.9%
Current ratio5.99
Liabilities / assets18.5%
Cash & investments$629.79M
Total debt$16.13M
Net cash (debt)$613.65M

Discussion

No comments yet — be the first to weigh in on SMMT.

Sign in to join the discussion.

Scroll to Top